The effect of mebudipine on cardiac function and activity of the myocardial nitric oxide system in ischaemia-reperfusion injury in rats

Cardiovascular Journal of Africa

Volumn 22, Issue 6, 2011, Pages 319-323

  Ghyasi, R ^a   Mohammadi, M ^b   Badalzadeh, R ^b,c   Rashidi, B ^d   Sepehri, G ^a  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ischaemia; Isolated heart; Mebudipine; Nitric oxide; Reperfusion

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CREATINE KINASE; DIHYDROPYRIDINE DERIVATIVE; LACTATE DEHYDROGENASE; MEBUDIPINE; NITRATE; NITRIC OXIDE; NITRITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG SCREENING; HEART FUNCTION; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; RAT; REPERFUSION INJURY; TISSUE LEVEL;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CORONARY CIRCULATION; CREATINE KINASE; HEART; L-LACTATE DEHYDROGENASE; MALE; MYOCARDIAL CONTRACTION; NIFEDIPINE; NITRATES; NITRIC OXIDE; NITRITES; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 83455219879     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2010-078     Document Type: Article

References (31)

1. Moens AL, Claeys MJ, Timmermans JP, Vrints M. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol 2005; 100: 179-190.
2. Gross GJ, Auchampach JA. Reperfusion injury: Does it exist? J Mol Cell Cardiol 2007; 42: 12-18. (Pubitemid 44958622)
3. De Groot H, Rauen U. Ischemia-reperfusion injury: Processes in pathogenetic networks. Transplant Proc 2007; 39: 481-484. (Pubitemid 46386215)
4. Rastaldo R, Pagliaro P, Capello S, Losano G. Nitric oxide and cardiac function. Life Sci 2007; 81: 779-793. (Pubitemid 47332516)
5. Andelova E, Bartekova M, Pancza D, Styk J, Ravingerova T. The role of NO in ischemia/reperfusion injury in isolated rat heart. J Gen Physiol 2005; 24: 411-426. (Pubitemid 43264066)
6. Ignarro L. J, Napoli C, Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circulation 2002; 90: 21-28. (Pubitemid 34074604)
7. Mery P. F, Lohmann S. M, Walter U, Fischmeister R. Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci 1991; 88: 1197-1201. (Pubitemid 21916192)
8. Katsumata Naoki, Ma Xin, Higuchi Hiroshi. Protective effect of diltiazem against ischemia-induced decreases in regional myocardial flow in rat heart. Eur J Pharmacol 2000; 398: 83-91.
9. Rousseau G, Provost P, Tran D, Caille G, Latour JG. Clentiazem given at reperfusion improves subendocardial reflow and reduces myocardial infarct size in the dog. J Pharmacol Exp Ther 1994; 268: 1252-1260. (Pubitemid 24100339)
10. Ver Donck, L, Van Reempts J, Vandeplassche G, Borgers M. A new method to study activated oxygen species induced damage in cardiomyocytes and protection by Ca2q-antagonists. J Mol Cell Cardiol 1988; 20: 811-823. (Pubitemid 18268416)
11. 2+ overload in cardiomyocytes and mechanical activities in vascular strips. Eur J Pharmacol 1996; 312: 195-202.
12. Dohi Y, Kojima M, Sato K. Benidipine improves endothelial function in renal resistance arteries of hypertensive rats. Hypertension 1996; 28: 58-63. (Pubitemid 26231091)
13. Karasawa A, Rochester A, Lefer A. Protection of endothelial damage and systemic shock by benidipine, a calcium antagonist, in rat subjected to splanchnic ischemia and reperfusion. Circ Shock 1991; 116: 77-165.
14. Node K, Kitakaze M, Yoshikawa H, Kosaka H, Hori M. Decreased plasma levels of nitric oxide in patients with essential hypertension. Hypertension 1997; 30: 405-408. (Pubitemid 27446100)
15. Bassenge E, Heusch G. Endothelial and neurohumoral control of coronary blood flow in health and disease. Rev Physiol Biochem Pharmacol 1990; 116: 77-165.
16. Sakaguchi M, Shibata T, Ahattori K, Hirai H, Hosono M, Aoyama T, et al. Orally administered benidipine and manidipine prevent ischemiareperfusion injury in the rat heart. Circ J 2004; 68: 241-246. (Pubitemid 38405017)
17. Asanuma H, Kitakaze M, Funaya H, Takashima S, Minamino T, Node K, et al. Nifedipine limits infarct size via NO-dependent mechanisms in dogs. Basic Res Cardiol 2001; 96(5): 497-505. (Pubitemid 34071100)
18. Rouzrokh A, Ebrahimi SA, Rahbr-Roshandel N, Mahmoudian M. Effect of mebudipine and dipodipine, two new channel blockers on voltage-activated calcium current in pc12 cells. Acta Physiol Hung 2007; 94(3): 199-207.
19. Mirkhani H, Dirin M, Yossef-Zadeh I. Mechanism of vasoselective action of mebodipin, a new calcium channel blocker. Vasc Pharmacol 2004; 42; 23-29. (Pubitemid 40128139)
20. Becker BF, Mobert J. Low-dose calcium anagonists reduce energy demand and cellular damage of isolated hearts during both ischemic and reperfusion. Naunyn-schmiedebergs Arch Pharmacol 1999; 360: 287-294. (Pubitemid 29480919)
21. Massoudy P, Bexker BF, Gerlach E. Preischemic as well as postischemic application of a calcium antagonist afford cardioprotection in the iscolated guinea pig heart. Cardiovas Res 1995; 29: 577-582.
22. Van der Heide R, Schwartz LM, Reimer KA. The novel calcium antagonist Ro 40-5967 limits myocardial infract size in the dog. Cardiovas Res 1994; 28: 1526-1532. (Pubitemid 24318267)
23. Sun J, Zhang X, Broderick M, Fein H. Measurement of nitric oxide production in biological systems by using Griess reaction assay. Sensors 2007; 3: 276-284. (Pubitemid 40643539)
24. Kitakaze M, Node K, Minamino T, Hori M. A Ca channel blocker, binidipine, increases coronary blood flow and attenuates the severity of myocardial ischemia via NO-dependent mechanisms in dogs. J Am Cardiol Coll 1999; 33(1); 242-249. (Pubitemid 29064100)
25. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci 1987; 84: 9265-9269.
26. Nakano A, Liu GS, Heusch G, Downey JM, Cohen MV. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol 2000; 32: 1159-1167.
27. Chen LY, Mehta JL. Evidence for the presence of L-arginine-nitric oxide pathway in human red blood cells: relevance in the effects of red blood cells on platelet function. J Cardiovasc Pharmacol 1998; 32: 57-61. (Pubitemid 28304694)
28. Berkels R, Stockklauser K, Rosen P, Rosen R. Current status of platelet NO synthases. Thromb Res 1997; 87: 51-55.
29. Farivar RS, Chobanian AV, Brecher P. Salicylate or aspirin inhibits the induction of the inducible nitric oxide synthase in rat cardiac fibroblasts. Circ Res 1996; 78: 759-768. (Pubitemid 26131359)
30. Rossoni G, Manfredi B, Colonna VD, Brini AT, Polvani G, Clement MG, Berti F. Nitric oxide and Prostacyclin pathway: an integrated mechanism that limits myocardial infarction progression in anaesthized rats. Pharmacol Res 2006; 53: 359-366.
31. Gupta M, Ober M, Patterson C, Al-Hassani M, Hart M. Nitric oxide attenuates H2O2-induced endothelial dysfunction; mechanisms of protection. Am J Physiol Lung Mol Physiol 2001; 280: L116-L126.